Clemastine Repairs Damage In Multiple Sclerosis MStranslate July 4, 2023 Clinical Trials, Neuroimaging, Remyelination Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is...
Clinically Stable MS & Magnetic Resonance Imaging MStranslate October 3, 2016 Neuroimaging, Research What is clinically stable multiple sclerosis? As most of you might be aware, the most common form of multiple sclerosis is relapsing-remitting MS...
Spinal Cord Lesions & The Risk of Relapse MStranslate December 14, 2015 Neuroimaging, Research Research Summary: Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis The background Magnetic resonance imaging or...
Safety of Gadolinium-based Contrast Agents for MRI MStranslate November 16, 2015 Neuroimaging The U.S. Food and Drug Administration recently issued a safety communication on the use of gadolinium-based contrast agents for Magnetic Resonance...
The PET/CT Scanner & Its Uses for Multiple Sclerosis MStranslate May 2, 2014 Neuroimaging Professor Roger Ordidge, Chair of Imaging Science at the University of Melbourne, provides an insight into the new PET/CT scanner located at the...
An Explanation of Magnetic Resonance Imaging (MRI) MStranslate May 1, 2014 Neuroimaging As magnetic resonance imaging (MRI) plays a key role in the diagnosis of multiple sclerosis, we took the opportunity to ask Professor Roger Ordidge,...
A New Technique to Assess Outcomes of Optic Neuritis MStranslate April 30, 2014 Neuroimaging Optic neuritis (inflammation of the optic nerve, (ON)) causes visual loss and is a common early symptom of multiple sclerosis (MS). Patients with ON...
Understanding the Different Outcomes of Optic Neuritis MStranslate April 29, 2014 Neuroimaging, Research Optic neuritis (inflammation of the optic nerve) is a common side-effect of multiple sclerosis (MS) and leads to many sight-related difficulties,...
